NCT00416637 2016-07-07
Bevacizumab in Treating Patients With Advanced Solid Tumors
Duke University
Phase 1 Completed
Clinical Trials
6 trialsNCT00276575 2014-11-19
Bevacizumab, Everolimus, and Erlotinib in Treating Patients With Advanced Solid Tumors
Duke University
Phase 1 Completed
NCT00357318 2014-02-24
Bevacizumab and Sunitinib in Treating Patients With Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed
NCT00550927 2013-05-15
Enzastaurin and Bevacizumab in Treating Patients With Locally Advanced or Metastatic Cancer
Eli Lilly and Company
Phase 1 Completed
NCT00049088 2013-01-24
Bortezomib and Docetaxel in Treating Patients With Advanced Solid Tumors
National Cancer Institute (NCI)
Phase 1 Terminated
NCT00005061 2012-07-18
Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Solid Tumors
European Organisation for Research and Treatment of Cancer - EORTC
Phase 1 Completed